1. 5 Oral selective tyrosine kinase 2 (TYK2) inhibition with BMS-986165 in patients with systemic lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study (PAISLEY). (April 2019) Authors: Singhal, Shalabh; Shah, Vaishali; Crater, Chris; Hobar, Coby; Nguyen, Hoang; Throup, John; Banerjee, Subhashis; Merrill, Joan T Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗